3008-61-5,
4-(Morpholinomethyl)thiazol-2-amine,
4-(morpholin-4-ylmethyl)-1,3-thiazol-2-amine,
4-Morpholin-4-ylmethyl-thiazol-2-ylamine,
4-[(morpholin-4-yl)methyl]-1,3-thiazol-2-amine,
4-(4-Morpholinylmethyl)-1,3-thiazol-2-amine,
C8H13N3OS,
MLS000056638,
ACMC-209hcy,
AC1M1KHL,
AC1Q52QH,
SCHEMBL307293,
CHEMBL1306277,
CTK4G4396,
DTXSID20366650,
GSAMTLRIAXVZHZ-UHFFFAOYSA-N,
REGID_for_CID_2125344,
HMS2354J16,
ANW-26768,
MFCD06340096,
ZINC15937689,
AKOS000533145,
MCULE-2550872074,
QC-6240,
4(1-morpholinomethyl)thiazol-2-ylamine,
4-(1-morpholinomethyl)thiazol-2-ylamine,
2-Thiazolamine,4-(4-morpholinylmethyl)-,
AJ-68045,
BAS 12541718,
BS-13743,
CJ-15254,
SC-52016,
SMR000063836,
4-(1-morpholinomethyl) thiazol-2-ylamine,
AB0062517,
TR-045293,
BB 0253133,
V5009,
EN300-10114,
K-7252,
M80336,
Z96092275,
F2158-0442,
4-Morpholin-4-ylmethyl-thiazol-2-ylamine;2-Thiazolamine, 4-(4-morpholinylmethyl)-,
CID2125344,
2-Thiazolamine, 4-(4-morpholinylmethyl)-,